Vytrus Biotech (XMAD:VYT) ROCE % : 11.78% (As of Jun. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Vytrus Biotech ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Vytrus Biotech's annualized ROCE % for the quarter that ended in Jun. 2024 was 11.78%.

Vytrus Biotech ROCE % Historical Data

The historical data trend for Vytrus Biotech's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vytrus Biotech ROCE % Chart

Vytrus Biotech Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

-5.40

4.00

7.20

9.84

6.03

Vytrus Biotech Semi-Annual Data
	Dec18	Dec19	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
ROCE %	Get a 7-Day Free Trial					13.23	6.22	7.96	3.88	11.78

Vytrus Biotech ROCE % Calculation

Vytrus Biotech's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	0.454	/	( ( (8.004 - 1.269)	+	(9.315 - 0.996) )	/ 2 )
	=	0.454	/	( (6.735	+	8.319)	/ 2 )
	=	0.454	/	7.527
	=	6.03 %

Vytrus Biotech's ROCE % of for the quarter that ended in Jun. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Jun. 2024 )		(Q: Dec. 2023 )		(Q: Jun. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Jun. 2024 )		(Q: Dec. 2023 )		(Q: Jun. 2024 )
	=	1.054	/	( ( (9.315 - 0.996)	+	(10.645 - 1.076) )	/ 2 )
	=	1.054	/	( ( 8.319	+	9.569 )	/ 2 )
	=	1.054	/	8.944
	=	11.78 %

(1) Note: The EBIT data used here is two times the semi-annual (Jun. 2024) EBIT data.

Vytrus Biotech (XMAD:VYT) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Vytrus Biotech ROCE % Related Terms

Thank you for viewing the detailed overview of Vytrus Biotech's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Vytrus Biotech Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vytrus Biotech SA (XMAD:VYT) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Sant Gaieta 121, 2nd, Terrassa, Barcelona, ESP, 08221

Website

https://www.vytrus.com

Vytrus Biotech SA develops natural active ingredients on an industrial scale. The natural actives offered by the company include Nectaria Lithops, Olea Vitae, Turmeric zen, Capilia Longa, Qura Noni.

Vytrus Biotech Headlines

No Headlines